antibiotic Archives -

Helping to support momentum on antimicrobial innovation

Undeterred by FDA setback, GSK snaps up Spero antibiotic

Phil Taylor antibiotic, antimicrobial resistance, fda, GSK, licensing, regulatory, Spero Therapeutics, tebipenem 0 Comment

GSK is paying $66 million upfront to license rights to Spero Therapeutics novel antibiotic tebipenem Hbr, unswayed by

Undeterred by FDA setback, GSK snaps up Spero antibiotic

https://pharmaphorum.com/news/undeterred-by-fda-setback-gsk-snaps-up-spero-antibiotic/

News/ News/ R&D

Data dive could give PolyPid antibiotic a lifeline

Phil Taylor anti-infectives, antibiotic, PolyPid, prevention, surgery 0 Comment

Shares in PolyPid have been under pressure after the Israeli biotech reported its antibiotic for surgical site infections

Data dive could give PolyPid antibiotic a lifeline

https://pharmaphorum.com/news/data-dive-could-give-polypid-antibiotic-a-lifeline/

Market Access/ News/ News

FDA rejection of Spero’s tebipenem ‘raises resistance threat’

Phil Taylor antibiotic, antimicrobial resistance, fda, regulatory, Spero Therapeutics, tebipenem 0 Comment

The FDA’s decision not to approve Spero Therapeutics’ oral antibiotic tebipenem Hbr for adults with complicated urinary tract

FDA rejection of Spero’s tebipenem ‘raises resistance threat’

https://pharmaphorum.com/news/fda-rejection-of-speros-tebipenem-raises-resistance-threat/

Market Access/ News/ News/ News/ R&D

Basilea preps key US filing for MRSA antibiotic ceftobiprole

Phil Taylor antibiotic, Basilea, ceftobiprole, infectious diseases, MRSA, Zevtera 0 Comment

Basilea Pharmaceutica may finally be able to bring its antibiotic ceftobiprole to the US market – 13 years

Basilea preps key US filing for MRSA antibiotic ceftobiprole

https://pharmaphorum.com/news/basilea-preps-key-us-filing-for-mrsa-antibiotic-ceftobiprole/

News/ News/ Patients

US study finds high rates of unneeded antibiotic prescribing

Phil Taylor antibiotic, antimicrobial resistance, patients, prescribing, US 0 Comment

A study has found that there is still a very high level of inappropriate antibiotic prescribing to patients

US study finds high rates of unneeded antibiotic prescribing

https://pharmaphorum.com/news/us-study-finds-high-rates-of-unneeded-antibiotic-prescribing/

News/ News/ Sales and Marketing

UK launches its ‘Netflix-style’ payment model for antibiotics

Phil Taylor antibiotic, antimicrobial resistance, Fetcroja, NHS, NICE, Pfizer, Shionogi, UK, value-based models, Zavicefta 0 Comment

The UK is poised to become the first country in the world to launch a new payment model

UK launches its ‘Netflix-style’ payment model for antibiotics

https://pharmaphorum.com/news/uk-launches-its-netflix-style-payment-model-for-antibiotics/

News

Sandoz, Ares extend digital alliance on antimicrobial resistance

Phil Taylor antibiotic, antimicrobial resistance, Ares Genetics, generic, infectious disease, OpGen, Sandoz 0 Comment

Novartis’ generics unit Sandoz has moved on to the next stage of a collaboration with Ares Genetics, which

Sandoz, Ares extend digital alliance on antimicrobial resistance

https://pharmaphorum.com/news/sandoz-ares-extend-digital-alliance-on-antimicrobial-resistance/

News/ News/ R&D

Pharma-backed antibiotic fund makes first investments

Phil Taylor AMR Action Fund, antibiotic, antimicrobial resistance, financing, infectious disease 0 Comment

Two years after it was first proposed and a year after it officially launched, the pharma-backed AMR Action

Pharma-backed antibiotic fund makes first investments

https://pharmaphorum.com/news/pharma-backed-antibiotic-fund-makes-first-investments/

News/ News/ R&D

Venatorx plans new antibiotic filing after phase 3 readout

Phil Taylor antibiotic, antimicrobial resistance, Venatorx Pharmaceuticals 0 Comment

Venatorx Pharma has moved a step closer to what has unfortunately become a rare event in pharma –

Venatorx plans new antibiotic filing after phase 3 readout

https://pharmaphorum.com/news/venatorx-plans-new-antibiotic-filing-after-phase-3-readout/

Trending

antibiotic

Login